Heart Attack Current Events | Heart Attack News | 9
|
| Page
9 of
81 |
1602 Results |
|
|
|
Sort By:
Page Views | Date |
SCAI highlights study using wireless technology to speed care of heart attack patients
Imagine paramedics mobilizing a team of cardiologists and nurses within minutes of arriving at the home of a person who is having a heart attack, simply by pressing a button that sends an electrocardiogram (ECG) over a wireless network. view more (2007-05-18)
Healing the heart with bone marrow cells
Researchers at the McEwen Centre for Regenerative Medicine at Toronto General Hospital have discovered the 'SOS' distress signal that mobilizes specific heart repair cells from the bone marrow to the injured heart after a heart attack. view more (2006-07-05)
Software helps doctors calculate heart attack risk
Pioneering computer software is helping doctors to decide how best to treat patients admitted to hospital with suspected heart attacks. view more (2006-10-16)
System to analyze beating heart stem cells could lead to heart attack treatments
New research at the University of Nottingham, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), is paving the way for techniques that use stem cells to repair the damage caused by heart attacks. view more (2007-07-30)
Medication does not appear to offer benefit for certain heart attack patients undergoing PCI
Use of the drug pexelizumab immediately before and for 24 hours after stent placement or angioplasty for certain heart attack patients did not have any significant treatment effect compared to placebo, according to a study in the January 3 issue of JAMA. The medication had shown promise in preliminary studies. view more (2007-01-03)
No 'convincing evidence' that glitazones work better than older diabetes drugs
There is no convincing evidence that the newer class of diabetes drugs, known as glitazones, offer real advantages over other diabetes drugs, when used on their own, concludes the Drug and Therapeutics Bulletin (DTB). view more (2008-04-10)
Blood pressure drug may have added benefit
University of Kentucky researchers have discovered a possible added benefit of a novel new drug that lowers blood pressure. view more (2008-02-15)
Heart attack prescription drug strategy may save lives and reduce healthcare costs
Full prescription coverage of heart drugs could help heart attack survivors live longer, better lives and lower the nation's healthcare costs, according to a new analysis reported in Circulation: Journal of the American Heart Association. view more (2008-02-19)
Drug-eluting stents better than bare-metal stents for heart attack patients
Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the... view more... (2009-09-28)
A missing enzyme conveys major heart protection in pre-clinical work
Mice born without a certain enzyme can resist the normal effects of a heart attack and retain nearly normal function in the heart's ventricles and still-oxygenated heart tissue, according to a study by researchers at Duke University Medical Center. view more (2009-03-31)
Use of amino acid supplement following a heart attack provides no benefit, may be harmful
Use of the amino acid supplement L-arginine following a heart attack does not improve certain cardiac functions and measurements and may be associated with an increased risk of death. view more (2006-01-04)
Cholesterol test at 50 spots those most at risk of heart disease
Measuring the cholesterol of everyone aged 50 years and over is a simple and efficient way of identifying those at high risk of heart disease in the general population, suggest researchers in this week’s BMJ. view more (2003-06-25)
Healthy men who drink moderately have reduced risk of heart attack
For men with healthy lifestyle habits, drinking moderate amounts of alcohol may be associated with a lower risk of heart attack than drinking heavily or not drinking at all. view more (2006-10-24)
New mechanical heart implanted at the MUHC
Surgeons at the MUHC have successfully implanted a new kind of mechanical heart in two patients, the first time this new technology has been used in Canada. view more (2005-11-01)
Stem cell therapies for heart disease -- 1 step closer
New research from the University of Bristol brings stem cell therapies for heart disease one step closer. The findings reveal that our bodies' ability to respond to an internal 'mayday' signal may hold the key to success for long-awaited regenerative medicine. view more (2008-10-31)
Heart derived stem cells develop into heart muscle
Dutch researchers at University Medical Center Utrecht and the Hubrecht Institute have succeeded in growing large numbers of stem cells from adult human hearts into new heart muscle cells. view more (2008-04-24)
Estrogen therapy does not appear to protect postmenopausal women from heart disease
Estrogen therapy does not appear to reduce the risk of heart attack or coronary death in healthy postmenopausal women, although some data suggest a lower coronary heart disease risk in women aged 50 to 59 years. view more (2006-02-14)
Study questions risks of anti-bleeding drug during heart surgery
Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery. view more (2007-05-30)
Garlic may protect the heart after heart surgery
Raw garlic consumption may help limit the damage done to the heart after surgery because if its natural antioxidant properties, according to a new study published in BMC Pharmacology. After a heart attack it is important to restore the flow of blood to the heart so that damage to the heart muscle can be minimised. However, the return of blood... view more... (2002-09-09)
Reanalysis of controversial meta-analysis says writing off rosiglitazone may be premature
Rosiglitazone, a drug marketed by GlaxoSmithKline as Avandia® for the treatment of type 2 diabetes, came under fire after an article published online May 21 by the New England Journal of Medicine linked it to significantly increased risk of heart attack and cardiovascular death. view more (2007-08-10)
|
|
| Page
9 of
81 |
1602 Results |
|
|
|
Sort By:
Page Views | Date |
|
